Cobalt Therapeutics, LLC offers products that fit seamlessly into current clinical settings and enhance their therapeutic offerings to patients, decrease costs, and improve outcomes.
These programs have been evaluated in randomized, controlled trials and published in leading peer-reviewed journals.
OCFighter™ (formerly BTSTEPS) was developed by a team of leading experts in the field on anxiety disorders which included Professor Isaac Marks, M.D., an internationally recognized authority on the treatment of Phobia and Anxiety. The program has been subject to clinical, randomized controlled trials and open studies in the United States and United Kingdom.
For more information about OCFighter’s awards, press coverage and impact click here.